Psychiatric outcome in patients with a psychogenic movement disorder: A prospective study

Neuropsychiatry, Neuropsychology and Behavioral Neurology

Volumn 14, Issue 3, 2001, Pages 169-176

  Feinstein, A ^a   Stergiopoulos, V ^a   Fine, J ^a   Lang, A E ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANXIETY NEUROSIS; ARTICLE; COMORBIDITY; DEPRESSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; PERSONALITY DISORDER; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SYMPTOMATOLOGY;

FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR DISORDERS; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SOMATOFORM DISORDERS;

EID: 0034880778     PISSN: 0894878X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Hysteria: A neurologist's view
2. Psychogenic movement disorders in neurology: Frequency and clinical spectrum
3. Psychogenic movement disorders: Frequency, clinical profile, and characteristics
4. Psychogenic movement disorders
5. Psychogenic dystonia
6. Psychogenic dystonia: A review of 18 cases
7. Psychogenic tremors
8. Diagnostic and pathophysiological aspects of psychogenic tremors
9. Psychogenic myoclonus
10. Psychogenic Parkinsonism
11. Hysterical gait disorders
12. Psychogenic dyskinesias in patients with organic movement disorders
13. Psychiatric and neurologic predictors of psychogenic pseudoseizure outcome
14. Phenomenology and psychopathology related to psychogenic movement disorders
15. Somatisation and conversion disorders: Co-morbidity and demographics at presentation
16. Course and outcome of conversion and somatisation disorders. A four year follow-up
17. Ten year prognosis of conversion disorder
18. Outcome in conversion disorder: A follow-up study
19. Motor conversion disorder: A prospective 2-5 year follow-up study
20. Slater revisited: 6-Year follow-up study of patients with medically unexplained symptoms
21. Anxious and non-anxious depression
22. The co-morbidity factor: Establishing the primary diagnosis in patients with patients with mixed symptoms of anxiety and depression
23. The effects of anxiety on psychiatric morbidity in patients with multiple sclerosis
24. A scaled version of the general health questionnaire
25. Emotional disturbance in multiple sclerosis: Validity of the General Health Questionnaire (GHQ)
26. Psychiatric disturbance in neurologic patients: Detection, recognition and hospital course
27. Psychiatric screening on a neurologic ward
28. Long term follow-up of psychogenic movement disorders
29. Clinical characteristics of patients with motor disability due to conversion disorder: A prospective control group study
30. Lifetime and 12-month prevalence of DSM-111-R psychiatric disorders in the United States
31. Depression and multiple sclerosis
32. Depression in cerebrovascular disease
33. Depression in Parkinson's disease
34. Anxiety and Parkinson's disease
35. Influence of personality disorders on therapy outcome in somatoform disorders at 2 year follow-up
36. The epidemiology of dysthymia in five communities: Rates, risks, comorbidity, and treatment
37. How disabled are patients with somatoform disorders
38. Effect of comorbid anxiety, depressive and personality disorders on treatment outcome of somatoform disorders